A citation-based method for searching scientific literature

Carol Aghajanian, Stephanie V Blank, Barbara A Goff, Patricia L Judson, Michael G Teneriello, Amreen Husain, Mika A Sovak, Jing Yi, Lawrence R Nycum. J Clin Oncol 2012
Times Cited: 781



Sandro Pignata, Domenica Lorusso, Florence Joly, Ciro Gallo, Nicoletta Colombo, Cristiana Sessa, Aristotelis Bamias, Vanda Salutari, Frédèric Selle, Simona Frezzini, Ugo De Giorgi, Patricia Pautier, Alessandra Bologna, Michele Orditura, Coraline Dubot, Angiolo Gadducci, Serafina Mammoliti, Isabelle Ray-Coquard, Elena Zafarana, Enrico Breda, Laure Favier, Antonio Ardizzoia, Saverio Cinieri, Rémy Largillier, Daniela Sambataro, Emmanuel Guardiola, Rossella Lauria, Carmela Pisano, Francesco Raspagliesi, Giovanni Scambia, Gennaro Daniele, Francesco Perrone. Lancet Oncol 2021
Times Cited: 11




List of shared articles



Times cited

Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
Gennaro Daniele, Francesco Raspagliesi, Giovanni Scambia, Carmela Pisano, Nicoletta Colombo, Simona Frezzini, Germana Tognon, Grazia Artioli, Angiolo Gadducci, Rossella Lauria,[...]. Int J Gynecol Cancer 2021
3

4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study.
Meiko Nishimura, Hideki Sakai, Takuma Onoe, Shogen Boku, Takaaki Yokoyama, Genmu Kadokura, Satoshi Morita, Noriyuki Katsumata, Koji Matsumoto. Int J Clin Oncol 2021
0

Chemotherapeutic Regimens and Chemotherapy-Free Intervals Influence the Survival of Patients with Recurrent Advanced Epithelial Ovarian Carcinoma: A Retrospective Population-Based Study.
Hsin-Ying Huang, Chun-Ju Chiang, Yun-Yuan Chen, San-Lin You, Heng-Cheng Hsu, Chao-Hsiun Tang, Wen-Fang Cheng. Int J Environ Res Public Health 2021
1

The use of bevacizumab is correlated with improved post-progression survival in advanced recurrent ovarian cancer.
Shintaro Yanazume, Takashi Ushiwaka, Mika Fukuda, Shinichi Togami, Masaki Kamio, Hiroaki Kobayashi. Jpn J Clin Oncol 2021
0

Clinical benefit of systemic therapies for recurrent ovarian cancer-ESMO-MCBS scores.
K E Broekman, M van Kruchten, H van Tinteren, C Sessa, M Jalving, A K L Reyners. ESMO Open 2021
0

Adjuvant and post-surgical treatment in high-grade epithelial ovarian cancer.
Georgina E Wood, Jonathan A Ledermann. Best Pract Res Clin Obstet Gynaecol 2021
0

Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices.
M Bartoletti, S C Cecere, L Musacchio, R Sorio, F Puglisi, S Pignata. ESMO Open 2021
2